首页   按字顺浏览 期刊浏览 卷期浏览 A phase II study of 4'-epirubicin in the treatment of poor‐risk Kaposi's sa...
A phase II study of 4'-epirubicin in the treatment of poor‐risk Kaposi's sarcoma and AIDS

 

作者: Frances Shepherd,   Ronald Burkes,   Karen Paul,   Paul Goss,  

 

期刊: AIDS  （OVID Available online 1991）
卷期: Volume 5, issue 3  

页码: 305-310

 

ISSN:0269-9370

 

年代: 1991

 

出版商: OVID

 

关键词: Kaposi's sarcoma;AIDS;epirubicin

 

数据来源: OVID

 

摘要:

Twenty-six patients with poor-risk Kaposi's sarcoma and AIDS were treated with epirubicin 90 mg/m2intravenously every 3 weeks. One patient achieved complete response and 10 achieved partial response (overall response rate 42.3%). The median time to treatment failure was 22 weeks. The dose-limiting toxicity was neutropenia.

 

点击下载:  PDF (440KB)



返 回